Cordlife Group Limited (SGX:P8A)

Market Cap	39.73M
Revenue (ttm)	27.84M
Net Income (ttm)	-18.69M
Shares Out	256.31M
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,500
Average Volume	10,205
Open	0.1550
Previous Close	0.1580
Day's Range	0.1550 - 0.1550
52-Week Range	0.1190 - 0.1850
Beta	0.52
RSI	51.53
Earnings Date	May 9, 2025

About Cordlife Group

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. It operates in two segments, Banking and Diagnostics. The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples. The Diagnostics segment offers diagnostic testing services, such as newborn genetic and metabolic screenings; pediatric vision and ear screenings; pediatric allergen test; and genetic talent test ...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 2001
• Employees: 538
• Stock Exchange: Singapore Exchange
• Ticker Symbol: P8A